Two Sigma Investments’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $181K | Sell |
13,522
-48,850
| -78% | -$652K | ﹤0.01% | 2886 |
|
|
2025
Q1 | $636K | Buy |
62,372
+28,708
| +85% | +$293K | ﹤0.01% | 2358 |
|
|
2024
Q4 | $533K | Buy |
33,664
+23,342
| +226% | +$370K | ﹤0.01% | 2447 |
|
|
2024
Q3 | $599K | Sell |
10,322
-25,957
| -72% | -$1.51M | ﹤0.01% | 2319 |
|
|
2024
Q2 | $1.66M | Buy |
36,279
+11,457
| +46% | +$524K | ﹤0.01% | 1602 |
|
|
2024
Q1 | $1.64M | Sell |
24,822
-6,750
| -21% | -$447K | ﹤0.01% | 1561 |
|
|
2023
Q4 | $1.26M | Buy |
+31,572
| New | +$1.26M | ﹤0.01% | 1868 |
|
|
2022
Q3 | – | Sell |
-55,561
| Closed | -$1.54M | – | 2595 |
|
|
2022
Q2 | $1.54M | Buy |
+55,561
| New | +$1.54M | 0.01% | 1285 |
|
|
2021
Q4 | – | Sell |
-26,404
| Closed | -$1.05M | – | 2857 |
|
|
2021
Q3 | $1.05M | Sell |
26,404
-2,544
| -9% | -$101K | ﹤0.01% | 1668 |
|
|
2021
Q2 | $1.23M | Buy |
28,948
+20,470
| +241% | +$869K | ﹤0.01% | 1584 |
|
|
2021
Q1 | $522K | Sell |
8,478
-15,999
| -65% | -$985K | ﹤0.01% | 1849 |
|
|
2020
Q4 | $1.73M | Buy |
+24,477
| New | +$1.73M | 0.01% | 1127 |
|